2025 Clinical Trials Oil Research and Development 
Cannabis Law Report
DECEMBER 23, 2021
Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals. billion by 2025.
Puff Puff Post
DECEMBER 28, 2018
One recent observational study has shown an astonishing success rate of 80% in reducing negative behavioral patterns in test subjects by using CBD oil. We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism. CBD Oil For Autism: Highlights.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SMPL
MAY 26, 2020
For years, he’d been determined to connect the nascent CBD research he heard about at symposiums abroad with the medical marijuana movement in California. CBD industry will be worth $16 billion by 2025. This makes further research very difficult to do, and causes sick people in many states to be treated as criminals.
Cannabis Law Report
JULY 15, 2022
Last week, federal Health Minister Greg Hunt announced changes to regulations that would allow for medicinal cannabis exports, capitalising on what the Government estimated would be a $70 billion industry by 2025. I know that Medifarm was the first fully licensed, so cultivation and manufacturing and research licensed company in Australia.
Cannabis Law Report
OCTOBER 17, 2019
Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. billion in 2025, according to Grandview Research.
Expert insights. Personalized for you.
96 
Let's personalize your content